UConn Faculty are invited to attend this presentation, which will focus on Pfizer’s implementation of a Portable, Continuous, Miniature, Modular (PCM&M) development and manufacturing technology platform for oral solid dose drug products and the role that this platform plays in the creation of a transformational development, manufacturing, and distribution paradigm.
Host: Dr. Susan Froshauer, President and CEO of CURE
Moderator: Max Reeve, Director of Drug Substance at Melinta Therapeutics
Speaker: Michael O'Brien, VP of PTx Pharmaceutical Sciences Technology & Innovation Group
Please join us 4:00pm, May 12th at the Anlyan Center. For additional details and to register:
https://www.eventbrite.com/e/transforming-pharmaceutical-development-manufacturing-and-distribution-through-low-cost-portable-tickets-16059944727
For more information, contact: CURE at 203-470-2720